2023 ABSTRACTING RESOURCES QUICK LINKS
2023 DISEASE INDEX: https://seer.cancer.gov/tools/casefinding/
Jan 1, 2023 & forward, SEER has discontinued COVID19 data collection (page 21): 2023-Implementation-Guidelines_20220901.pdf
Extent of Disease (EOD) General Instructions
Extent of Disease (EOD)
SEER*RSA Staging Assistant
SEER Coding & Staging Manual 2023
Solid Tumor Rules 2023
Grade Manual
Site Specific Data Items (SSDI)
STORE manual
ICD-O-3 Coding Guidelines & Updates
SEER Inquiry System / SINQ
CAnswer Forum (AJCC, CoC, STORE, NAPBC, NAPRC)
SEER Drug Database
SEER Hematopoietic & Lymphoid Neoplasm Database
NPI Registry / National Provider Identifier Physician Look Up
KCR Public Site
Appendix C Site Groups
Membership & Education
National Cancer Registrars Association
INACCESSIBLE LYMPH NODE RULE
Page 23, Extent of Disease (EOD) 2018, General Coding Instructions (published October 2022): https://seer.cancer.gov/tools/staging/eod/
RADIO-SENSITIZING CHEMOTHERAPY: If chemotherapy was provided as a radiosensitizer or radioprotectant DO NOT code as chemotherapy treatment. When chemotherapy is given for radiosensitization or radioprotection it is given in low doses that do not affect the cancer. Please review the treatment plan or reach out to the physicians administering treatment for confirmation.